Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2026, 4:00 PM EST
Plandaí Biotechnology Revenue
Plandaí Biotechnology had revenue of $80.82K in the quarter ending September 30, 2016, with 271.69% growth. This brings the company's revenue in the last twelve months to $338.48K, up 215.33% year-over-year. In the fiscal year ending June 30, 2016, Plandaí Biotechnology had annual revenue of $298.49K with 221.31% growth.
Revenue (ttm)
338.48K
Revenue Growth
+215.33%
P/S Ratio
0.13
Revenue / Employee
1.88K
Employees
180
Market Cap
44.89K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2016 | 298.49K | 205.60K | 221.31% |
| Jun 30, 2015 | 92.90K | -172.84K | -65.04% |
| Jun 30, 2014 | 265.74K | -93.41K | -26.01% |
| Jun 30, 2013 | 359.14K | 284.69K | 382.38% |
| Jun 30, 2012 | 74.45K | - | - |
| Jun 30, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| XCPCNL Business Services | 6.40M |
| Allegiant Professional Business Services | 4.65M |
| Evolution Technology Resources | 2.45M |
| Imagexpres | 2.06M |
| Frontera Group | 872.52K |
| Proto Script Pharmaceutical | 604.98K |
| Discount Print USA | 344.43K |
| All American Pet Company | 206.27K |
Plandaí Biotechnology News
- 2 years ago - Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet's (A Subsidiary Of Plandai – $PLPL) Business and Assets - Accesswire
- 2 years ago - Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O'Shea - Accesswire
- 2 years ago - ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams - Accesswire
- 2 years ago - ByoPlanet and Merck Animal Health Announce Partnership with USEF - Accesswire
- 2 years ago - Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health - Accesswire
- 2 years ago - Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus - Accesswire
- 2 years ago - ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology - Accesswire
- 3 years ago - Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC - Accesswire